Any update on breezula? Or PTD - DBM Research/Science 7/1/2021
The conversation is about updates on hair loss treatments Breezula or PTD-DBM. No new information was provided.
View this post in the Community →
Similar Community Posts Join
5 / 338 resultscommunity Breezula disappearing like my hair follicles.
Breezula's development has stalled, leaving users disappointed. The conversation includes skepticism about its approval and effectiveness.
community Breezula - who tried CB0301/Clascoterone from gray marked/pharmas ?
The conversation discusses using CB0301/Clascoterone as a potential treatment for hair loss, especially for those experiencing side effects from finasteride and dutasteride. The user currently uses oral minoxidil and considers combining it with other treatments like kx826, DHT blocker supplements, and 2% Nizoral shampoo.
community How likely is Breezula going to come and be a 'cure' for people who can't use finasteride?
Breezula may be released around 2027 but its effectiveness for advanced thinning is uncertain, and it might be expensive. Users discuss alternatives like low-dose topical finasteride and combining it with Breezula for better results.
community Breezula Phase 3 confusion - did they change something?
Breezula's phase 2 showed reduced efficacy after 6 months, but phase 3 had positive results, causing confusion about any changes made to the drug. There is frustration over the long timeline for hair loss treatments, with some users expressing more interest in other potential treatments like GT-20029.
community Breezula sold at Anagen Inc & Universal Labs - has anyone tried it?
Breezula is being sold at Anagen Inc and Universal Labs, and users are discussing their experiences and results with it. There is also interest in the formulation process and inquiries about PP405.
Related Research
6 / 15 resultsresearch Breezula, A Clinical Stage Topical Anti-Androgen, Promotes Dermal Papilla Inductivity And Reduces IL-6 Secretion In Balding Skin Samples Ex Vivo
Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.
research Androgenetic Alopecia: An Update Of Treatment Options
Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.
research New Drugs Under Investigation for the Treatment of Alopecias
New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.
research Androgenetic Alopecia: Combing the Hair Follicle Signaling Pathways for New Therapeutic Targets and More Effective Treatment Options
New treatments for hair loss may target specific pathways and generate new hair follicles.
research Experimental and Early Investigational Drugs for Androgenetic Alopecia
New hair loss treatments may include topical medications, injections, and improved transplant methods.
research Biotechs Target Stagnant Baldness Market
New drug shows promise for better hair growth in baldness treatment.